Codes / ICD10CM / T83.714D

T83.714D Erosion of implanted ureteral bulking agent to surrounding organ or tissue, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Erosion of implanted ureteral bulking agent to surrounding organ or tissue, subsequent encounter

Summary

Erosion of implanted ureteral bulking agent, subsequent encounter, refers to a follow-up visit for complications where the bulking agent used to treat ureteral conditions has worn through or into adjacent organs or tissues. This requires ongoing medical evaluation and intervention to address tissue damage, discomfort, and related complications.

Causes

The condition may result from factors such as improper surgical technique, infection, inflammation, or the body's reaction to the bulking agent. Over time, physical stress or degradation of the implant may also contribute to erosion. Subsequent encounters indicate ongoing management of these issues.

Risk Factors

  • Prior surgeries involving ureteral implants
  • Infections or chronic inflammation
  • Physical activity placing stress on the implant site
  • Smoking or conditions affecting healing
  • Individual sensitivity to foreign materials

Symptoms

  • Pain or discomfort at the implant site
  • Abnormal discharge or bleeding
  • Urinary problems, such as incontinence or urgency
  • Signs of tissue exposure or damage
  • Infection-related symptoms (e.g., fever, redness)

Diagnosis

Diagnosis typically involves a physical examination to assess the implant site and surrounding tissues. Imaging studies like ultrasound or MRI may be used to evaluate the extent of erosion. Additional procedures, such as cystoscopy, might be performed for detailed assessment of affected tissues or organs.

Treatment Options

Treatment may include non-surgical management, such as monitoring and symptom relief, or surgical intervention to remove or repair the eroded material. The approach depends on the severity of erosion and associated complications.

Prognosis and Follow-Up

Prognosis varies based on the extent of erosion and response to treatment. Regular follow-up is essential to monitor healing, address complications, and adjust management as needed. Long-term outcomes depend on the success of intervention and patient-specific factors.

Complications

  • Persistent pain or discomfort
  • Infection at the implant site
  • Urinary tract obstruction or dysfunction
  • Tissue damage requiring further surgery
  • Delayed healing or chronic inflammation

Lifestyle & Prevention

  • Avoid activities that stress the implant site until cleared by a healthcare provider.
  • Maintain good hygiene to reduce infection risk.
  • Follow post-surgical guidelines for activity and care.
  • Address underlying conditions like inflammation promptly.

When to Seek Professional Help

Seek medical attention if symptoms worsen, new symptoms develop, or signs of infection (e.g., fever, increased pain) occur. Prompt evaluation is important to prevent further complications.

Tips for Medical Coders

Document the subsequent encounter clearly, noting the status of the erosion and any interventions performed. Ensure the code T83.714D is used for encounters specifically related to the erosion of implanted ureteral bulking agent, with documentation supporting the ongoing nature of the condition.

Book a walkthrough

T83.714D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.